Treatment of Chemotherapy Refractory Human Epidermalgrowth Factor Receptor-2( HER-2) Positive Advanced Solid Tumors

NCT01935843 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Advanced HER-2 Positive Solid Tumors
Chemotherapy Refactory
HER-2 Antibody Inhibitor Therapy Refactory

Interventions

BIOLOGICAL: CART-HER-2

Sponsor

Chinese PLA General Hospital